Experimental Alzheimer’s drug reverses genetic changes thought to spur the disease

When given to old rats, the drug, which is known to affect signaling by the neurotransmitter glutamate, reversed many age-related changes that occur in a brain region key to learning and memory. The drug also produced effects opposing those seen in the brains of Alzheimer’s patients.